Mostrar el registro sencillo del ítem

dc.contributor.author
Navarro Marin, Fernanda  
dc.contributor.author
Franzen, Jaqueline Maisa  
dc.contributor.author
Troyner, Fernanda  
dc.contributor.author
Molina, Victor Alejandro  
dc.contributor.author
Giachero, Marcelo  
dc.contributor.author
Bertoglio, Leandro Jose  
dc.date.available
2023-08-29T14:23:33Z  
dc.date.issued
2020-12  
dc.identifier.citation
Navarro Marin, Fernanda; Franzen, Jaqueline Maisa; Troyner, Fernanda; Molina, Victor Alejandro; Giachero, Marcelo; et al.; Taking advantage of fear generalization-associated destabilization to attenuate the underlying memory via reconsolidation intervention; Pergamon-Elsevier Science Ltd; Neuropharmacology; 181; 108338; 12-2020; 1-11  
dc.identifier.issn
0028-3908  
dc.identifier.uri
http://hdl.handle.net/11336/209737  
dc.description.abstract
Upon retrieval, an aversive memory can undergo destabilization and reconsolidation. A traumatic-like memory, however, may be resistant to this process. The present study sought to contribute with a strategy to overcome this potential issue by investigating whether generalized fear retrieval is susceptible to destabilization-reconsolidation that can be pharmacologically modified. We hypothesized that exposure to a context that elicits moderate generalization levels would allow a malleable memory state. We developed a fear conditioning protocol in context A (cxt-A) paired with yohimbine administration to promote significant fear to a non-conditioned context B (cxt-B) in rats, mimicking the enhanced noradrenergic activity reported after traumatic events in humans. Next, we attempted to impair the reconsolidation phase by administering clonidine (CLO) immediately after exposure to cxt-A, cxt-B, or a third context C (cxt-C) neither conditioned nor generalized. CLO administered post-cxt-B exposure for two consecutive days subsequently resulted in decreased freezing levels in cxt-A. CLO after cxt-B only once, after cxt-A or cxt-C in two consecutive days, or independently of cxt-B exposures did not affect fear in a later test. A 6-h-delay in CLO treatment post-cxt-B exposures produced no effects, and nimodipine administered pre-cxt-B exposures precluded the CLO action. We then quantified the Egr1/Zif268 protein expression following cxt-B exposures and CLO treatments. We found that these factors interact to modulate this memory destabilization-reconsolidation mechanism in the basolateral amygdala but not the dorsal CA1 hippocampus. Altogether, memory destabilization can accompany generalized fear expression; thus, we may exploit it to potentiate reconsolidation blockers' action.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Pergamon-Elsevier Science Ltd  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/  
dc.subject
FEAR OVERGENERALIZATION  
dc.subject
MEMORY LABILIZATION  
dc.subject
MEMORY MODIFICATION  
dc.subject
MEMORY REACTIVATION  
dc.subject
POSTTRAUMATIC STRESS DISORDER  
dc.subject.classification
Neurociencias  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Taking advantage of fear generalization-associated destabilization to attenuate the underlying memory via reconsolidation intervention  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2023-08-28T12:57:16Z  
dc.journal.volume
181  
dc.journal.number
108338  
dc.journal.pagination
1-11  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Amsterdam  
dc.description.fil
Fil: Navarro Marin, Fernanda. Universidade Federal de Santa Catarina; Brasil  
dc.description.fil
Fil: Franzen, Jaqueline Maisa. Universidade Federal de Santa Catarina; Brasil  
dc.description.fil
Fil: Troyner, Fernanda. Universidade Federal de Santa Catarina; Brasil  
dc.description.fil
Fil: Molina, Victor Alejandro. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Farmacología Experimental de Córdoba. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Instituto de Farmacología Experimental de Córdoba; Argentina  
dc.description.fil
Fil: Giachero, Marcelo. Universidade Federal de Santa Catarina; Brasil. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Neurociencias Cognitivas y Traslacional; Argentina. Universidad Favaloro; Argentina  
dc.description.fil
Fil: Bertoglio, Leandro Jose. Universidade Federal de Santa Catarina; Brasil  
dc.journal.title
Neuropharmacology  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1016/j.neuropharm.2020.108338  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0028390820304068